Advancing Care in Myeloproliferative Neoplasms:From Established Standards to Future Treatment Paradigms is organized by Medical Learning Institute Inc (MLI).
Release Date: Oct 14, 2026
Expiration Date: Oct 13, 2027
Description:
MPN care is advancing fast, but translating molecular findings, prognostic scores, and symptom data into a coherent, risk-adapted plan remains a real challenge at the point of care. This symposium gives the full care team a practical framework — so you can stratify risk accurately, select therapy with confidence, and personalize treatment across PV, ET, and MF. As novel mechanisms of action, combination regimens, and anemia-targeting therapies enter the MPN landscape, clinicians face growing uncertainty about where each option fits. Learn to evaluate emerging and established therapies side by side, anticipate and manage adverse events, and deliver comprehensive, longitudinal care that improves outcomes.
Learning Objectives:
After completing this activity, the participant should be better able to:
Credits:
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education:
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
Notice to Diplomates: MLI will report any claimed MOC/Lifelong Learning points to the appropriate Board within 4 weeks of completing the activity. Please ensure that you have provided your Board ID number and MMDD of birth.
For Canadian Physicians:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
EBAH:
Medical Learning Institute Inc is an accredited CME-CPD provider by the European Board for Accreditation in Hematology (EBAH).
This educational activity has been accredited for a maximum number of 1.0 EBAH CME-CPD credits. Each participant should only collect credits for time that she/he actually spent in the educational activity.
Note: All training activities accredited by the EBAH (European Board of Accreditation in Hematology; http://ebah.org) are automatically recognised by the SSH.
PA:
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until October 13, 2027. PAs should only claim credit commensurate with the extent of their participation.
Pharmacy:
Medical Learning Institute Inc designates this application-based continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
Nursing Continuing Professional Development:
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 0.33 contact hour in the area of pharmacology.
The numerical value indicated on the document is the maximum amount of points that can be claimed in each subject area. The total amount of ILNA points claimed may not exceed the total amount of NCPD awarded from this course and may only apply to the credential each nurse is renewing.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved